Trial Details

TERMINATED
Basic Information
Clinical ID c2818
Identifier NCT02914600
Trial Title Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Crohn's Disease
Interventions DRUG: Filgotinib|DRUG: Placebo
Participant Information
Sponsor Galapagos NV
City Dothan
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2017-03-17
Primary Completion Date 2023-08-01
Completion Date 2023-08-01